Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 October 2023 | Story Nonsindiso Qwabe | Photo Nonsindiso Qwabe
Mokitlane Manyarela
Mokitlane Manyarela reflects on his 41-year journey with the UFS Qwaqwa Campus

He has seen the many changing faces of the Qwaqwa Campus, and four decades later, Mokitlane Manyarela says he would not have it any other way.

Fondly known on campus as ‘Ntate Manyarela’, he has been with the campus for 41 years, having started on 1 January 1982 at the ripe age of 18 years. Manyarela recently received a long-service award for 36 years of service, dating back to when the campus moved to its current location from where it started at Lere la Tshepe in 1982.

He recalls arriving at the campus offices in town in 1982 seeking employment, as there were no “buildings or campus” back then.

“I started working as a general worker because there was nothing else to do. All the university’s content would come from Turfloop in those days. As time went by, I worked in the reprographic section, printing exam papers. That was my first official job until the campus moved in 1988 to where we’re now located. All the buildings that are now filling this campus were constructed right in front of my eyes,” he said.

He went on to work for various departments on the campus, such as procurement, cashiers, and finance. In 2007, he joined the transport department, and that is where he is still working as an assistant officer. “What’s made me stay this long is not getting into fights with anyone and always following instructions given to me. I’ve worked under many different bosses, and I believe that none of them have anything negative to say about me. Therefore, I can say I’ve never had a reason to leave because everything I’ve done, I have done wholeheartedly.”

Manyarela said the university also afforded his wife and children the opportunity to obtain their degrees, which is something he considers a huge achievement. “All that I have has been achieved at this institution. It’s been a wonderful journey. I have no complaints, and I am content. I’ve reached my old age here. I don’t know any other job or work environment; this place has become like home to me, and I’m prepared to still give my all to this university, even though old age is now catching up with me.”

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept